Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02663271
Title TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Florida
Indications

glioblastoma

Therapies

Bevacizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.